Abiopharma

Clinical trial NCT01829568: completion date: 2026-06-06 → 2027-06-06.

Clinical trial NCT07596784: allocation: NA → NON_RANDOMIZED.

Clinical trial NCT06562907 updates: 1. completion date: 2026-07-01 → 2026-11-01 2. primary completion date: 2026-07-01 → 2026-11-01

Clinical trial NCT02386800 updates: 1. status: ACTIVE_NOT_RECRUITING → RECRUITING 2. completion date: 2027-09-16 → 2032-04-05 3. enrollment: 279 → 296 participants 4. enrollment type: ACTUAL → ESTIMATED

Clinical trial NCT07570966 updates: 1. status: NOT_YET_RECRUITING → WITHDRAWN 2. enrollment: 217 → 0 participants 3. enrollment type: ESTIMATED → ACTUAL

Transcat Announces Appointment of Roy Simmons as Chief Strategy and Corporate Development Officer

Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA

SEALSQ’s QS7001 Post-Quantum Secure Element Aligned with New ANSSI Post Quantum Mandate

Greenland Mines Signs Drilling Contract with Nordisk Fundering for Expanded 2026 Skaergaard Diamond Drilling Program in Greenland

Saratoga Investment Corp. to Report Fiscal First Quarter 2027 Financial Results and Hold Conference Call